【导读】 招证国际向其全资子公司分次增资不超过90亿港元 中国基金报记者 莫琳 12月6日，在中国证券业协会第八次会员大会上，证监会主席吴清提到，强大的金融机构是金 融强国的核心要素，国际一流金融机构需具备全球资本配置能力、资产定价话语权、顶尖人 才储备及国际金融治理引领力。行业机构需对标这一目标，加快提升核心竞争力，为金融强 国建设筑牢产业基础。 招商证券以实际行动响应。 12月8日，招商证券发布第八届董事会第二十五次会议决议公告提到，董事会会议同意由招证 国际向其全资子公司分次增资不超过90亿港元。 首次增资对象为招商证券（香港）有限公司，增资规模不超过40亿港元。同意授权招证国际 董事会根据实际情况决定对其全资子公司分次增资并办理增资相关事宜。 据了解，招商证券通过全资子公司招证国际开展国际业务。招证国际在中国香港、英国及韩 国等地设立子公司，通过子公司分别经营证券及期货合约经纪、上市保荐、财务顾问、企业 融资、投资管理、资产管理、市场研究等业务，以及子公司所在地监管规则允许的其他业 务。 据记者统计，今年以来，已有山西证券、中信建投等券商公布了对其海外子公司的增资计 划，增资金额最多15亿港元。招商证 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容 而產生或因依賴該等內容而引致的任何損失承擔任何責任。 （ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） （股份代號：6099） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條規則作出。 茲載列招商證券股份有限公司在上海證券交易所網站刊登之《招商證券股份有限公司第八 屆董事會第二十五次會議決議公告》，僅供參閱。 承董事會命 招商證券股份有限公司 霍達 董事長 招商证券股份有限公司 第八届董事会第二十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 招商证券股份有限公司（以下简称公司）第八届董事会第二十五次会议通知 于 2025 年 12 月 4 日以电子邮件方式发出。会议于 2025 年 12 月 8 日以通讯表决 方式召开。 本次会议由霍达董事长召集。应出席董事 14 人 ...

北京商报讯（记者 李海媛）12月8日，招商证券发布第八届董事会第二十五次会议决议公告提到，董事 会会议同意由招证国际向其全资子公司分次增资不超过90亿港元。首次增资对象为招商证券（香港）有 限公司，增资规模不超过40亿港元。同意授权招证国际董事会根据实际情况决定对其全资子公司分次增 资并办理增资相关事宜。 ...

招商证券(600999.SH)公告称，公司第八届董事会第二十五次会议审议通过关于招证国际向其全资子公 司增资的议案，同意由招证国际向其全资子公司分次增资不超过90亿港元，首次增资对象为招商证券 （香港）有限公司，增资规模不超过40亿港元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Core Viewpoint - The report from China Merchants Securities highlights that YingShi Innovation is a leader in the panoramic camera market, expanding into action cameras, wearable cameras, gimbals, and drone markets, while also beginning to develop software solutions [1] Group 1: Market Position and Expansion - YingShi Innovation is recognized as the leading company in the panoramic camera sector [1] - The company is gradually extending its product line to include action cameras, wearable cameras, and gimbals, as well as entering the drone market to enhance flight experiences [1] Group 2: Market Potential - The transition from the panoramic camera market, valued in the tens of billions, to the action camera and drone markets, which are valued in the hundreds of billions, indicates significant growth potential [1] Group 3: Investment Outlook - The firm is optimistic about YingShi's core positioning in the smart imaging device sector, product innovation, technological leadership, and long-term growth prospects [1] - A first-time "Buy" rating has been assigned, emphasizing the scarcity of smart imaging brands and the growth potential of the business, suggesting active monitoring of the company [1]

Market Overview - The Hong Kong stock market faced pressure, with the Hang Seng Index dropping over 1%, closing at 25,965.36 points, down 1.23% or 319.72 points, with a total turnover of HKD 2,062.3 million [1] - The Hang Seng China Enterprises Index fell by 1.25% to 9,083.53 points, while the Hang Seng Tech Index remained flat at 5,662.55 points [1] Blue Chip Performance - Baidu Group-SW (09888) led blue-chip stocks, rising 3.45% to HKD 125.8, contributing 8.38 points to the Hang Seng Index [2] - Other notable performers included SMIC (00981) up 2.94%, China Ping An (02318) up 2.15%, while China Construction Bank (00939) fell 4.01%, dragging the index down by 54.39 points [2] Sector Highlights - Large tech stocks generally declined, with Alibaba down over 1% and Tencent down 0.82% [3] - Chinese brokerage stocks rose against the trend, with Huatai Securities (06886) up 5.17% and GF Securities (01776) up 3.1% [3] - The light communication sector saw significant gains, with Huiju Technology rising over 7% [4] - Lithium stocks mostly increased, with Ganfeng Lithium (01772) up 6.95% and CATL (03750) up 3.28% [5] Regulatory Developments - The Chairman of the China Securities Regulatory Commission (CSRC) emphasized the need to accelerate the development of top-tier investment banks and institutions, indicating a potential easing of regulations for quality institutions [4] - The CSRC plans to optimize risk control indicators and moderately open up capital space and leverage limits, which could benefit leading brokerages [4] New Listings and Stock Movements - Two new stocks were listed, with Zhuoyue Ruixin (02687) surging 87.26% and Naxinwei (02676) declining 4.31% [7] - Restructured Energy (02570) faced a significant drop of 27.33% on its first trading day after the lock-up period ended [8] - Silver Pharma-B (02591) saw a decline of 14.32% following its inclusion in the Hong Kong Stock Connect [9] - Sutech (02498) performed well, rising 5.23% after securing a major order from FAW Toyota [10] Pharmaceutical Sector Updates - The National Healthcare Security Administration announced the addition of 114 new drugs to the 2025 National Medical Insurance Drug List, with a success rate of 88%, up from 76% in 2024 [6]

Market Overview - The Hong Kong stock market faced pressure, with the Hang Seng Index dropping over 1%, closing at 25,965.36 points, down 1.23% or 319.72 points, with a total turnover of HKD 206.23 billion [1] - The Hang Seng China Enterprises Index fell by 1.25% to 9,083.53 points, while the Hang Seng Tech Index remained flat at 5,662.55 points [1] Blue Chip Performance - Baidu Group-SW (09888) led blue-chip stocks, rising 3.45% to HKD 125.8, contributing 8.38 points to the Hang Seng Index [2] - Other notable performers included SMIC (00981) up 2.94% and China Ping An (02318) up 2.15%, while China Construction Bank (00939) fell 4.01%, dragging the index down by 54.39 points [2] Sector Highlights - Major technology stocks generally declined, with Alibaba down over 1% and Tencent down 0.82% [3] - Chinese brokerage stocks rose against the trend, with Huatai Securities (06886) up 5.17% and GF Securities (01776) up 3.1% [3][4] - The light communication sector saw significant gains, with Huiju Technology (01729) rising 7.65% [4] - Lithium stocks mostly increased, with Ganfeng Lithium (01772) up 6.95% and CATL (03750) up 3.28% [5] Regulatory Developments - The Chairman of the China Securities Regulatory Commission (CSRC) emphasized the need to accelerate the development of top-tier investment banks and institutions, indicating a potential easing of regulations for quality institutions [4] - The CSRC plans to optimize risk control indicators and open up capital space and leverage limits [4] New Drug Listings - The National Healthcare Security Administration announced the addition of 114 new drugs to the 2025 National Medical Insurance Drug List, with a success rate of 88%, significantly higher than the previous year's 76% [6] New Listings and Stock Movements - New listings included Zhuoyue Ruixin (02687), which surged 87.26% to HKD 126.4, while Naxin Micro (02676) fell 4.31% [7] - Restructured Energy (02570) saw a significant drop of 27.33% on its first trading day after the lock-up period ended [8] - Silver Pharma-B (02591) experienced a decline of 14.32% as it was adjusted into the Hong Kong Stock Connect [9] - Sutech (02498) performed well, rising 5.23% after securing a major contract with FAW Toyota [10]

具体来看： 大型科技股多数呈现下跌行情但总体跌幅较小，腾讯、京东、网易、小米、京东跌幅在1%以内，阿里巴巴、快手、携程控股跌超 1%，百度逆市大涨3.45%。 | 代码 | 名称 | 最新价 | 涨跌额 | 涨跌幅 √ | | --- | --- | --- | --- | --- | | 09888 | 百度集团-SW.) | 125.800 | +4.200 | 3.45% | | 03690 | 美团-W | 99.500 | +0.450 | 0.45% | | 09626 | 時陣時陣-W | 203.600 | -0.200 | -0.10% | | 02015 | 理想汽车-W | 69.650 | -0.250 | -0.36% | | 01810 | 小米集团-W | 42.580 | -0.200 | -0.47% | | 099999 | 网易-5 | 216.800 | -1.200 | -0.55% | | 09618 | 京东集团-SW | 116.200 | -0.800 | -0.68% | | 00700 | 腾讯控股 | 605.000 | -5.000 | -0.82% ...

本次会议由霍达董事长召集。应出席董事 14 人，实际出席董事 14 人。 证券代码：600999 证券简称： 招商证券 编号： 2025－051 招商证券股份有限公司 第八届董事会第二十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 招商证券股份有限公司（以下简称公司）第八届董事会第二十五次会议通知 于 2025 年 12 月 4 日以电子邮件方式发出。会议于 2025 年 12 月 8 日以通讯表决 方式召开。 本次会议的召集、召开及表决程序符合有关法律、行政法规、部门规章、规 范性文件和《招商证券股份有限公司章程》的规定。 二、董事会会议审议情况 议案表决情况：同意 14 票，反对 0 票，弃权 0 票。 （二）关于修订《招商证券股份有限公司经理层成员岗位聘任协议》的议 案 议案表决情况：同意 14 票，反对 0 票，弃权 0 票。 特此公告。 招商证券股份有限公司董事会 2025 年 12 月 8 日 （一）关于招证国际向其全资子公司增资的议案 同意由招证国际向其全资子公司分次增 ...

（记者 曾健辉） 截至发稿，招商证券市值为1463亿元。 每经头条（nbdtoutiao）——处方药变"瘾品"：国内首次报告普瑞巴林滥用致成瘾病例，网络平台暴 露"无病历可购药"漏洞，列管与否尚需科学考量 每经AI快讯，招商证券（SH 600999，收盘价：16.82元）12月8日晚间发布公告称，公司第八届第二十 五次董事会会议于2025年12月8日以通讯表决方式召开。会议审议了《关于招证国际向其全资子公司增 资的议案》等文件。 2025年1至6月份，招商证券的营业收入构成为：证券经纪业务占比56.39%，证券投资业务占比 24.32%，其他占比10.57%，资产管理业务占比4.9%，投资银行业务占比3.83%。 ...